BELINDA MULL: Open Payments
NPI 1831172527 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 19 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $460 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $201 |
| Novo Nordisk Inc | 4 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| PFIZER INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: BREZTRI, Ozempic, Kerendia, PREVNAR 20, AIRSUPRA, ROTATEQ, FARXIGA, EVENITY.
Industry payments across NC — which companies pay providers there.
